Auxilium submits Xiaflex BLA

Auxilium (NASDAQ:AUXL) submitted a BLA to FDA for Xiaflex clostridial collagenase to treat Dupuytren's contracture. The company requested Priority Review for the injectable form of collagenase ABC enz...